News for ELI LILLY (LLY.BE)

AbCellera (Nasdaq: ABCL) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has i...

Europe's medicines regulator said on Friday Eli Lilly and Co's antibody drug combination can be used to treat COVID-19 patients who do not require oxygen support and are at high risk of progressing to... | March 5, 2021

INDIANAPOLIS, March 5, 2021 /PRNewswire/ -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company (NYSE: LLY), today a...

Eli Lilly (LLY) closed the most recent trading day at $200.54, moving -0.72% from the previous trading session.

The National Institutes of Health said Thursday that it is putting three more investigational COVID-19 treatments into Phase 2/3 clinical trials. The...

March 4, 2021 (Investorideas.com Newswire) This latest undertaking of Dicerna Pharmaceuticals and the near-term catalysts of some of its other programs are desc...

A recent market study published by Future Market Insights (FMI) on the GLP-1 Receptor Agonist Market offers global industry analysis for 2015-2019 &

Activist investor Starboard Value LP has taken a stake in Elanco Animal Health Inc. and nominated three directors to the company’s board, according to people familiar with the matter.

The Cboe Volatility Index, or VIX, is an index created by Cboe Global Markets, which shows the market's expectation of 30-day volatility.

Hilton's (NYSE: HLT) innovative hotel brand, Tru by Hilton, today announced the opening of its latest property, Tru by Hilton Indianapolis Downtown. The 148-room hotel, located at 601 Russel Avenue, is owned by MWA, LLC and managed by Dora Hospitality LLC.

Junshi Biosciences and Coherus BioSciences Announce Initiation of Rolling Submission of BLA for Toripalimab to the U.S. FDA for the Treatment of Nasopharyngeal Carcinoma GlobeNewswire March 03, 2021 - BLA submitted with FDA’s breakthrough therapy designation –

Psoriasis treatment has expanded dramatically over the past decade, and the growth shows no signs of stopping, as many prominent players such as Abbvie, Jannsen, Dermavant Sciences, UCB, Eli Lilly and Company, Boehringer Ingelheim, Pfizer, Arcutis Biotherapeutics, Amgen, Mylan, Clover Biopharmaceuticals, Sienna Biopharmaceuticals, Fresenius Kabi, Celltrion, Bristol Myers Squibb, LEO Pharma, Crescita Therapeutics, GlaxoSmithKline, Coherus BioSciences, Fujifilm Kyowa Kirin Biologics, Zydus Cadilla, Shanghai Henlius Biotech, Hetero Biopharma, CinnaGen, Biocad, Torrent Pharmaceuticals, Alvotech, Maruho Co., Ltd., Arcutis Biotherapeutics, Inc., Eli Lilly and Company, Can-Fite Biopharma, MetrioPharm, Provectus Pharmaceuticals, Sienna Biopharmaceuticals and many others are developing Psoriasis therapies.

March 2021 Forward-Looking Statement This presentation contains forward-looking statements relating to, among other things, the commercial... | March 2, 2021

INDIANAPOLIS, March 2, 2021 /PRNewswire/ -- OneAmerica ® has elected Linda Need, FSA ®, CFA ®, CFP ®, CAP ®  and Ryan Kitchell, CFA ®, to its board of

Peptide Therapeutics Market Set for Linear Growth at 11% CAGR through 2030; Market to Witness Decline in Near Term Due to COVID-19 Pandemic

According to a Healthcare Expert at Future Market Insights, “Factors such as growing prevalence of chronic diseases in dogs, rising pets adoption, increased

Covina CA, March 02, 2021 (GLOBE NEWSWIRE) -- Global Oral Solid Dosage Excipients Market accounted for US$ 2.8 billion in 2020 and is estimated to be US$ ...

A Trio of Stocks With a Record of Operating Income Margin Growth, Stocks: MA,HD,LLY, release date:Mar 01, 2021

A Trio of Stocks With a Record of Operating Income Margin Growth, Stocks: MA,HD,LLY, release date:Mar 01, 2021